Clinical Trial Update: Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 003 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial for Group ACYW135 meningococcal polysaccharide vaccine 003 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis

Drugs mentioned

• Group ACYW135 Meningococcal Polysaccharide Vaccine 003 (Meningococcal polysaccharide vaccine ACYW135 group)

Snippet

Sponsor: Hualan Biological Engineering, Inc. | Conditions: Meningitis | Phase 3 | Status: COMPLETED